Olema Pharmaceuticals, Inc. (OLMA) Insider Trading
Over the last 6 months, 139 institutions increased and 91 reduced their position (13F).
Insider Activity
Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Dec
Jan
Sep
Dec
Jan
Mar
Context3-month price -56.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 29, 2026 | Raman Prakashdirector | Grant | 24,150 | $14.59 |
| Apr 29, 2026 | Raman Prakashdirector | Grant | 2,911 | $14.59 |
| Mar 5, 2026 | Mitchell Shawnteofficer: CHIEF LEGAL OFFICER | Sell | 233 | $24.69 |
| Mar 5, 2026 | Mitchell Shawnteofficer: CHIEF LEGAL OFFICER | Option | 25,000 | $4.37 |
| Mar 5, 2026 | Mitchell Shawnteofficer: CHIEF LEGAL OFFICER | Sell | 24,767 | $24.25 |
| Mar 5, 2026 | Mitchell Shawnteofficer: CHIEF LEGAL OFFICER | Sell | 15,000 | $23.01 |
| Mar 5, 2026 | Mitchell Shawnteofficer: CHIEF LEGAL OFFICER | Option | 15,000 | $4.37 |
| Feb 17, 2026 | Austin Sasha Luofficer: VP of Finance and Controller | Grant | 29,250 | $25.65 |
| Feb 17, 2026 | Austin Sasha Luofficer: VP of Finance and Controller | Grant | 11,700 | — |
| Feb 4, 2026 | Bohen Seandirector, officer: PRESIDENT AND CEO | Grant | 850,000 | $25.65 |
| Feb 4, 2026 | Mitchell Shawnteofficer: CHIEF LEGAL OFFICER | Grant | 56,250 | $25.65 |
| Feb 4, 2026 | Mitchell Shawnteofficer: CHIEF LEGAL OFFICER | Grant | 220,000 | $25.65 |
| Feb 4, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Grant | 106,250 | $25.65 |
| Feb 4, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Grant | 250,000 | $25.65 |
| Feb 4, 2026 | Zojwalla Naseemofficer: CHIEF MEDICAL OFFICER | Grant | 106,250 | $25.65 |
| Feb 4, 2026 | Zojwalla Naseemofficer: CHIEF MEDICAL OFFICER | Grant | 250,000 | $25.65 |
| Feb 4, 2026 | Bohen Seandirector, officer: PRESIDENT AND CEO | Grant | 275,000 | $25.65 |
| Jan 21, 2026 | Harmon Cyrusdirector | Sell | 10,000 | $26.88 |
| Jan 16, 2026 | Harmon Cyrusdirector | Sell | 3,489 | $29.12 |
| Jan 15, 2026 | Kovacs Shane William Charlesofficer: CH. OPERATING & FINANCIAL OFF. | Sell | 100,000 | $28.73 |
| Jan 15, 2026 | Kovacs Shane William Charlesofficer: CH. OPERATING & FINANCIAL OFF. | Sell | 3,822 | $28.01 |
| Jan 14, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Option | 50,000 | $4.87 |
| Jan 14, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Sell | 200 | $28.49 |
| Jan 14, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Sell | 49,800 | $27.60 |
| Jan 14, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Sell | 14,997 | $28.60 |
| Jan 14, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Sell | 10,000 | $28.34 |
| Jan 14, 2026 | Myles David C.officer: CH. DISCOV. & NON-CLIN DEV OFF | Sell | 35,003 | $28.99 |
| Dec 29, 2025 | Harmon Cyrusdirector | Sell | 2,881 | $28.53 |
| Dec 23, 2025 | CLARK IAN Tdirector | Sell | 41,840 | $30.48 |
| Dec 23, 2025 | Zojwalla Naseemofficer: Chief Medical Officer | Sell | 12,921 | $28.93 |
Source: OLMA SEC Form 4 filings, latest Apr 29, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their OLMA positions over the last 6 months (SEC Form 13F).
Increased
139
New positions
134
Reduced
91
Sold out
64
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 10.4M | May 15, 2026 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Increased | 8.5M | Feb 17, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Increased | 8.0M | May 15, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Increased | 7.5M | Feb 17, 2026 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Reduced | 7.5M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 7.1M | May 18, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 6.7M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 5.7M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 5.6M | Feb 12, 2026 |
| BVF INC/IL | Unchanged | 5.3M | Feb 17, 2026 |
| BVF INC/IL | Unchanged | 5.3M | May 15, 2026 |
| FMR LLC | Increased | 5.0M | Feb 17, 2026 |
| SIREN, L.L.C. | Increased | 4.8M | May 14, 2026 |
| STATE STREET CORP | Increased | 3.9M | May 15, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | Increased | 3.9M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.